| 1. |
Chiotan C, Radu L, Serban R, et al. Cytomegalovirus retinitis in HIV/AIDS patients[J]. J Med Life, 2014, 7(2): 237-240.
|
| 2. |
朱雪菲, 陸云峰, 陸培榮, 等. 白血病患者巨細胞病毒性視網膜炎的臨床特點和療效觀察[J]. 中華眼底病雜志, 2018, 34(1): 43-46. DOI: 10.3760/cma.j.issn.1005-1015.2018.01.011.Zhu XF, Lu YF, Lu PY, et al. Clinical characteristics and treatment of cytomegalovirus retinitis in leukemia[J]. Chin J Ocul Fundus Dis, 2018, 34(1): 43-46. DOI: 10.3760/cma.j.issn.1005-1015.2018.01.011.
|
| 3. |
孫揮宇, 李丹, 毛菲菲, 等. 獲得性免疫缺陷綜合征合并巨細胞病毒性視網膜炎的特殊眼底病變特征[J]. 中華眼底病雜志, 2014, 30(3): 309-311. DOI: 10.3760/cma.j.issn.1005-1015.2014.03.020.Sun HY, Li D, Mao FF, et al. Characteristics of special fundus lesions in acquired immune deficiency syndrome with cytomegalovirus retinitis[J]. Chin J Ocul Fundus Dis, 2014, 30(3): 309-311. DOI: 10.3760/cma.j.issn.1005-1015.2014.03.020.
|
| 4. |
馬楠, 葉俊杰, 李東輝, 等. 免疫重建炎癥綜合征的眼部病變[J]. 中華眼科雜志, 2014, 50(8): 593-597. DOI: 10.3760/cma.j.issn.0412-4081.2014.08.009.Ma N, Ye JJ, Li DH, et al. Ocular manifestations of immune reconstitution inflammatory syndrome[J]. Chin J Ophthalmol, 2014, 50(8): 593-597. DOI: 10.3760/cma.j.issn.0412-4081.2014.08.009.
|
| 5. |
Urban B, Bakunowicz-?azarczyk A, Michalczuk M. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment[J/OL]. Mediators Inflamm, 2014, 2014: 971417[2014-06-24]. https://pubmed.ncbi.nlm.nih.gov/25089078/.DOI: 10.1155/2014/971417.
|
| 6. |
Yeo TH, Yeo TK, Wong EP, et al. Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore[J/OL]. J Ophthalmic Inflamm Infect, 2016, 6(1): 41[2016-11-07]. https://pubmed.ncbi.nlm.nih.gov/27822743/.DOI: 10.1186/s12348-016-0110-3.
|
| 7. |
Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis[J]. Ophthalmology, 1985, 92(4): 467-471. DOI: 10.1016/s0161-6420(85)34001-0.
|
| 8. |
Nguyen QD, Kempen JH, Bolton SG, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy[J]. Am J Ophthalmol, 2000, 129(5): 634-639. DOI: 10.1016/s0002-9394(00)00356-1.
|
| 9. |
Henderson HW, Mitchell SM. Treatment of immune recovery vitritis with local steroids[J]. Br J Ophthalmol, 1999, 83(5): 540-545. DOI: 10.1136/bjo.83.5.540.
|
| 10. |
Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis[J]. Am J Ophthalmol, 1998, 125(3): 292-300. DOI: 10.1016/s0002-9394(99)80134-2.
|
| 11. |
Karavellas MP, Lowder CY, Macdonald C, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome[J]. Arch Ophthalmol, 1998, 116(2): 169-175. DOI: 10.1001/archopht.116.2.169.
|
| 12. |
Wang B, Tian B, Tao Y, et al. Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis[J]. J Ocul Pharmacol Ther, 2014, 30(7): 587-592. DOI: 10.1089/jop.2013.0241.
|
| 13. |
余盈盈, 趙明威, 苗恒. 基于房水病毒學和炎性細胞因子檢測的巨細胞病毒性視網膜炎治療模式的初步研究[J]. 中華眼底病雜志, 2020, 36(1): 1-4. DOI: 10.3760/cma.j.issn.1005-1015.2020.01.001.Yu YY, Zhao MW, Miao H. Regime for cytomegalovirus retinitis based on aqueous virology and inflammatory cytokine determination[J]. Chin J Ocul Fundus Dis, 2020, 36(1): 1-4. DOI: 10.3760/cma.j.issn.1005-1015.2020.01.001.
|